发明名称 A SYNERGISTIC COMBINATION OF MEDICAMENTS CONTAINING AS ACTIVE SUBSTANCE ALPHA-LIPOIC ACID, DIHYDROLIPOIC ACID, THEIR METABOLITES AS WELL AS THE OXIDIZED AND REDUCED ENANTIONMERS OF ALPHA-LIPOIC ACID SUCH AS R-ALPHA-LIPOIC ACID OR S-ALPHA-LIPOIC ACID AS WELL AS METABOLITES OF ALPHA-LIPOIC ACID WITH THE VITAMINS A, B1-6, B12, C AND E
摘要 The use of alpha-lipoic acid, dihydrolipoic acid, metabolites of alpha-lipoic acid, inter alia 6,8- bisnortetralipoic acid, tetranorlipoic acid, optical isomers R- and S-form of alpha-lipoic acid in oxidized and reduced form in combination with vitamin A, B1, B2, B6, B12, C and E and their pharmaceutically acceptable salts for the preparation of medicaments with analgesic, anti-inflammatory, antidiabetic, cytoprotective, anti-ulcer, antinecrotic, neuroprotective, detoxifying, anti-ischemic, liver function regulating, anti-allergic, immune-stimulating and antioncogenic effect, corresponding medicaments and their preparation.
申请公布号 CA2097732(A1) 申请公布日期 1993.12.06
申请号 CA19932097732 申请日期 1993.06.04
申请人 WEISCHER, CARL-HEINRICH;ULRICH, HEINZ;WESSEL, KLAUS 发明人 WEISCHER, CARL-HEINRICH;ULRICH, HEINZ;WESSEL, KLAUS
分类号 A61K9/08;A61K9/10;A61K9/107;A61K9/20;A61K9/48;A61K31/07;A61K31/355;A61K31/375;A61K31/385;A61K31/44;A61K31/51;A61K31/525;A61K31/714;A61K47/04;A61K47/10;A61K47/12;A61K47/16;A61K47/18;A61K47/20;A61K47/22;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/40;A61K47/42;A61K47/44;A61K47/48;A61P3/02;A61P3/10;A61P9/10;A61P25/00;A61P25/04;A61P29/00;A61P35/00;A61P37/04;A61P39/02;(IPC1-7):A61K31/385 主分类号 A61K9/08
代理机构 代理人
主权项
地址